A business executive with a career spanning more than 40 years, John Klein is the current chairman and former CEO of Cambridge Therapeutics, a pharmaceutical company based in New Jersey. John Klein and the firm’s leadership are focused on three primary goals: the development of drug-combination therapies, physician prescription dispensing, and novel-drug delivery.

The company’s drug-delivery approach centers on an innovative method of dispensing medication that makes it easy and efficient for doctors to take over the responsibility of providing patients with necessary prescriptions. While conventional practices in the provision of these products have relied on pharmacists to individually count and hand-fill bottles for patients, the company aims to simplify this act through the development of its patented Compliance PACs.

The Compliance PACs offer an unique opportunity to prevent counting errors through clearly-detailed dosage information and pill appearance. The packs are distinctly labeled with easy-to-read instructions and are simple for an adult to open while still maintaining a childproof mechanism. The prepackaged nature of Cambridge Therapeutics-supplied medications also means that doctors could have the ability to dispense medication directly to the client, rather than needing to send a prescription to a pharmacist for pickup.

The Compliance PACs are specially designed to combat nonadherence in patients, which is a serious and sometimes life-threatening issue.